Obesity is the biggest risk factor for Type 2 diabetes, and substantial weight loss can help in reversal and remission of the disease, as well as reduced risk for conditions like high blood pressure, dyslipidemia, heart disease, and stroke
Prescribers should also consider whether the benefits of concurrent use outweigh the risks, and whether alternative treatment strategies might be more appropriate for the individual patient
For context, lets examine cost per potential benefit: Kind Patches calculation: 12 monthly with no proven weight loss = incalculable cost per kg lost (since no weight loss is demonstrated) Prescription GLP-1 comparison: Mounjaro costs 229-299 monthly but typically produces 15-25% weight loss in clinical trials
Foods like prunes, dried apricots, berries, vegetables, whole grains, and legumes can support regular bowel movements
The EMA notes that about 1 in 10,000 Ozempic patients may experience this rare side effect
Healthy habits extend results